MannKind Corp Net Income
| MNKD Stock | USD 5.66 0.03 0.53% |
As of the 14th of February 2026, MannKind Corp secures the Downside Deviation of 2.87, mean deviation of 1.94, and Risk Adjusted Performance of 0.0376. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of MannKind Corp, as well as the relationship between them. Please verify MannKind Corp treynor ratio, as well as the relationship between the downside variance and kurtosis to decide if MannKind Corp is priced some-what accurately, providing market reflects its recent price of 5.66 per share. Given that MannKind Corp has jensen alpha of 0.0456, we recommend you to check MannKind Corp's last-minute market performance to make sure the company can sustain itself at a future point.
MannKind Corp Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 5.0531 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 31.7 M | 33.3 M | |
| Net Income From Continuing Ops | 31.7 M | 33.3 M | |
| Net Loss | -100.5 M | -105.5 M | |
| Net Income Per Share | 0.09 | 0.10 | |
| Net Income Per E B T | 0.81 | 0.80 |
MannKind | Net Income | Build AI portfolio with MannKind Stock |
Analyzing MannKind Corp's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing MannKind Corp's current valuation and future prospects.
Latest MannKind Corp's Net Income Growth Pattern
Below is the plot of the Net Income of MannKind Corp over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in MannKind Corp financial statement analysis. It represents the amount of money remaining after all of MannKind Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is MannKind Corp's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MannKind Corp's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 27.59 M | 10 Years Trend |
|
Net Income |
| Timeline |
MannKind Net Income Regression Statistics
| Arithmetic Mean | (81,680,723) | |
| Coefficient Of Variation | (141.52) | |
| Mean Deviation | 85,499,908 | |
| Median | (80,926,000) | |
| Standard Deviation | 115,598,451 | |
| Sample Variance | 13363T | |
| Range | 494.1M | |
| R-Value | 0.52 | |
| Mean Square Error | 10335.3T | |
| R-Squared | 0.27 | |
| Significance | 0.03 | |
| Slope | 12,002,673 | |
| Total Sum of Squares | 213808T |
MannKind Net Income History
Other Fundumenentals of MannKind Corp
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
MannKind Corp Net Income component correlations
MannKind Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for MannKind Corp is extremely important. It helps to project a fair market value of MannKind Stock properly, considering its historical fundamentals such as Net Income. Since MannKind Corp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of MannKind Corp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of MannKind Corp's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Biotechnology sector continue expanding? Could MannKind diversify its offerings? Factors like these will boost the valuation of MannKind Corp. Expected growth trajectory for MannKind significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every MannKind Corp data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.35) | Earnings Share 0.1 | Revenue Per Share | Quarterly Revenue Growth 0.172 | Return On Assets |
Investors evaluate MannKind Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating MannKind Corp's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause MannKind Corp's market price to deviate significantly from intrinsic value.
Understanding that MannKind Corp's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether MannKind Corp represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, MannKind Corp's market price signifies the transaction level at which participants voluntarily complete trades.
MannKind Corp 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to MannKind Corp's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of MannKind Corp.
| 11/16/2025 |
| 02/14/2026 |
If you would invest 0.00 in MannKind Corp on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding MannKind Corp or generate 0.0% return on investment in MannKind Corp over 90 days. MannKind Corp is related to or competes with Aurinia Pharmaceuticals, Harmony Biosciences, Celldex Therapeutics, Vera Therapeutics, Janux Therapeutics, Abcellera Biologics, and Nuvation Bio. MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeut... More
MannKind Corp Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure MannKind Corp's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess MannKind Corp upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.87 | |||
| Information Ratio | 0.0115 | |||
| Maximum Drawdown | 12.99 | |||
| Value At Risk | (4.67) | |||
| Potential Upside | 4.09 |
MannKind Corp Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for MannKind Corp's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as MannKind Corp's standard deviation. In reality, there are many statistical measures that can use MannKind Corp historical prices to predict the future MannKind Corp's volatility.| Risk Adjusted Performance | 0.0376 | |||
| Jensen Alpha | 0.0456 | |||
| Total Risk Alpha | (0.11) | |||
| Sortino Ratio | 0.0106 | |||
| Treynor Ratio | 0.121 |
MannKind Corp February 14, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0376 | |||
| Market Risk Adjusted Performance | 0.131 | |||
| Mean Deviation | 1.94 | |||
| Semi Deviation | 2.55 | |||
| Downside Deviation | 2.87 | |||
| Coefficient Of Variation | 2630.91 | |||
| Standard Deviation | 2.64 | |||
| Variance | 6.96 | |||
| Information Ratio | 0.0115 | |||
| Jensen Alpha | 0.0456 | |||
| Total Risk Alpha | (0.11) | |||
| Sortino Ratio | 0.0106 | |||
| Treynor Ratio | 0.121 | |||
| Maximum Drawdown | 12.99 | |||
| Value At Risk | (4.67) | |||
| Potential Upside | 4.09 | |||
| Downside Variance | 8.23 | |||
| Semi Variance | 6.52 | |||
| Expected Short fall | (2.31) | |||
| Skewness | (0.57) | |||
| Kurtosis | 1.03 |
MannKind Corp Backtested Returns
MannKind Corp appears to be somewhat reliable, given 3 months investment horizon. MannKind Corp has Sharpe Ratio of 0.0921, which conveys that the firm had a 0.0921 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for MannKind Corp, which you can use to evaluate the volatility of the firm. Please exercise MannKind Corp's Mean Deviation of 1.94, downside deviation of 2.87, and Risk Adjusted Performance of 0.0376 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, MannKind Corp holds a performance score of 7. The company secures a Beta (Market Risk) of 0.75, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, MannKind Corp's returns are expected to increase less than the market. However, during the bear market, the loss of holding MannKind Corp is expected to be smaller as well. Please check MannKind Corp's treynor ratio, kurtosis, period momentum indicator, as well as the relationship between the downside variance and day median price , to make a quick decision on whether MannKind Corp's current price movements will revert.
Auto-correlation | 0.11 |
Insignificant predictability
MannKind Corp has insignificant predictability. Overlapping area represents the amount of predictability between MannKind Corp time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of MannKind Corp price movement. The serial correlation of 0.11 indicates that less than 11.0% of current MannKind Corp price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.11 | |
| Spearman Rank Test | 0.22 | |
| Residual Average | 0.0 | |
| Price Variance | 0.04 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
MannKind Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, MannKind Corp reported net income of 27.59 M. This is 91.92% lower than that of the Biotechnology sector and 60.61% lower than that of the Health Care industry. The net income for all United States stocks is 95.17% higher than that of the company.
MannKind Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MannKind Corp's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MannKind Corp could also be used in its relative valuation, which is a method of valuing MannKind Corp by comparing valuation metrics of similar companies.MannKind Corp is currently under evaluation in net income category among its peers.
MannKind Corp ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, MannKind Corp's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to MannKind Corp's managers, analysts, and investors.Environmental | Governance | Social |
MannKind Corp Institutional Holders
Institutional Holdings refers to the ownership stake in MannKind Corp that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of MannKind Corp's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing MannKind Corp's value.| Shares | Bank Of America Corp | 2025-06-30 | 3.4 M | Nuveen, Llc | 2025-06-30 | 3.2 M | Tsp Capital Management Group/llc | 2025-06-30 | 3 M | Northern Trust Corp | 2025-06-30 | 2.8 M | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 2.8 M | Charles Schwab Investment Management Inc | 2025-06-30 | 2.6 M | 180 Wealth Advisors, Llc | 2025-06-30 | 2.6 M | Two Sigma Investments Llc | 2025-06-30 | 2.5 M | D. E. Shaw & Co Lp | 2025-06-30 | 2.5 M | Blackrock Inc | 2025-06-30 | 29.1 M | Vanguard Group Inc | 2025-06-30 | 18.2 M |
MannKind Fundamentals
| Return On Asset | 0.0995 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.23 % | ||||
| Current Valuation | 1.59 B | ||||
| Shares Outstanding | 307.07 M | ||||
| Shares Owned By Insiders | 1.64 % | ||||
| Shares Owned By Institutions | 55.15 % | ||||
| Number Of Shares Shorted | 26.24 M | ||||
| Price To Earning | 2.27 X | ||||
| Price To Sales | 5.54 X | ||||
| Revenue | 285.5 M | ||||
| Gross Profit | 235.9 M | ||||
| EBITDA | 77.47 M | ||||
| Net Income | 27.59 M | ||||
| Cash And Equivalents | 154.16 M | ||||
| Cash Per Share | 0.60 X | ||||
| Total Debt | 47.7 M | ||||
| Debt To Equity | 9.93 % | ||||
| Current Ratio | 3.25 X | ||||
| Book Value Per Share | (0.14) X | ||||
| Cash Flow From Operations | 42.51 M | ||||
| Short Ratio | 5.18 X | ||||
| Earnings Per Share | 0.10 X | ||||
| Price To Earnings To Growth | (0.23) X | ||||
| Target Price | 9.44 | ||||
| Number Of Employees | 403 | ||||
| Beta | 0.81 | ||||
| Market Capitalization | 1.56 B | ||||
| Total Asset | 393.84 M | ||||
| Retained Earnings | (3.2 B) | ||||
| Working Capital | 186.47 M | ||||
| Current Asset | 76.65 M | ||||
| Current Liabilities | 268.32 M | ||||
| Net Asset | 393.84 M |
About MannKind Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MannKind Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MannKind Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MannKind Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether MannKind Corp is a strong investment it is important to analyze MannKind Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MannKind Corp's future performance. For an informed investment choice regarding MannKind Stock, refer to the following important reports:Check out For information on how to trade MannKind Stock refer to our How to Trade MannKind Stock guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Will Biotechnology sector continue expanding? Could MannKind diversify its offerings? Factors like these will boost the valuation of MannKind Corp. Expected growth trajectory for MannKind significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every MannKind Corp data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.35) | Earnings Share 0.1 | Revenue Per Share | Quarterly Revenue Growth 0.172 | Return On Assets |
Investors evaluate MannKind Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating MannKind Corp's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause MannKind Corp's market price to deviate significantly from intrinsic value.
Understanding that MannKind Corp's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether MannKind Corp represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, MannKind Corp's market price signifies the transaction level at which participants voluntarily complete trades.